[Prolonged neuromuscular paralysis following simultaneous administration of amikacin and pancuronium].
D000583:Amikacin / Q000008:administration & dosage / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*; D010197:Pancuronium / Q000008:administration & dosage / Q000009:adverse effects*; D010291:Paresis / Q000139:chemically induced*
D000900:Anti-Bacterial Agents; D009466:Neuromuscular Blocking Agents; D007612:Kanamycin; D000583:Amikacin; D010197:Pancuronium
Parálisis neuromuscular prolongada tras administración simultánea de amikacina y pancuronio.